JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1970) 47, 1-11    DOI: 10.1677/joe.0.0470001
© 1970 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SHENKIN, A.
Right arrow Articles by DICK, W. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SHENKIN, A.
Right arrow Articles by DICK, W. C.

THE LYSINE-VASOPRESSIN TEST: AN EVALUATION OF TWO METHODS OF ADMINISTRATION IN NON-CORTICOSTEROID-TREATED AND CORTICOSTEROID-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS

A. SHENKIN, G. NUKI, R. M. LINDSAY, K. WHALEY, W. W. DOWNIE and W. C. DICK

The response of plasma 11-hydroxycorticosteroids (11-OHCS) to parenteral lysine-vasopressin (LVP) was studied in 47 patients with rheumatoid arthritis, 25 of whom had received long-term oral corticosteroid therapy; the remaining 22 had received no oral corticosteroids at any time, and served as controls. Both groups of patients showed excellent reproducibility of the plasma 11-OHCS response to LVP, when administered intravenously or intramuscularly. Comparable plasma 11-OHCS levels were reached in control patients when the intravenous LVP test was carried out in the morning and in the evening. Criteria of a normal response to both intramuscular and intravenous LVP were defined. In the control group, intravenous infusion of LVP led to a more sustained plasma 11-OHCS response than did intramuscular injection of the same dose. No such differences were observed in the corticosteroid-treated group, but the intramuscular test was subnormal more frequently than the intravenous test.

In the control patients, insulin-induced hypoglycaemia and intravenous LVP led to comparable plasma 11-OHCS response, although a higher mean level at 60 min. was observed in the former. This difference was not observed in the corticosteroid-treated patients.

Direct comparison of these three tests lead to the conclusion that the intramuscular LVP test is more sensitive than the intravenous LVP test, but less sensitive than the insulin hypoglycaemia test, in detecting corticosteroid-induced suppression of hypothalamo-pituitary-adrenal function. The intramuscular LVP test is therefore to be preferred to the intravenous test because of its greater sensitivity, its relative lack of side-effects, and its ease of performance.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the Society for Endocrinology.